Evidence map›Paper›PMID 28799020›Full record

ReviewJournal of bioenergetics and biomembranes2017

From discovery of the CHOP axis and targeting ClpP to the identification of additional axes of the UPRmt driven by the estrogen receptor and SIRT3.

Timothy C Kenny, Doris Germain

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of bioenergetics and biomembranes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Mitochondrial dysfunction, UPRCell & bioscience · 2021
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Mitohormesis, UPRCancer research · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Timothy C KennyDepartment of Medicine, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, 10029, USA.
Doris GermainDepartment of Medicine, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, 10029, USA. doris.germain@mssm.edu.
Icahn School of Medicine at Mount Sinai · USTisch Cancer Institute

Funding

The role of the SIRT3 axis of the mitochondrial UPR in breast cancer metastasisF31CA228259 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KENNY, TIMOTHY COLE · 2018 to 2020
$92k
NCI NIH HHS F31 CA228259
6 · The paper itself

Abstract

The mitochondrial UPR (UPR

Indexed as

AnimalsEndopeptidase ClpHumansMitochondriaMitochondrial ProteinsNeoplasmsReceptors, EstrogenSirtuin 3Transcription Factor CHOPUnfolded Protein ResponseClpP protein, humanDDIT3 protein, humanEndopeptidase ClpMitochondrial ProteinsReceptors, EstrogenSIRT3 protein, humanSirtuin 3Transcription Factor CHOPCHOPClpPEstrogen receptorMitochondrial UPRSirtuinUPRmt

Identifiers

PMID28799020
OpenAlexW2744227069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.